Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Huffman

Showing results (161-170 of 325) with videos related to

Pageof 33
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|August 10, 2020
Monitoring and implementation of salt reduction initiatives in Africa: A systematic reviewDejen Yemane Tekle, Joseph Alvin Santos, Kathy Trieu, et al.
Journal of the American College of Cardiology|November 10, 2016
Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of CardiologyDonald M Lloyd-Jones, Mark D Huffman, Kunal N Karmali, et al.
Journal of the American Heart Association|November 23, 2020
Adverse Trends in Premature Cardiometabolic Mortality in the United States, 1999 to 2018Nilay S Shah, Donald M Lloyd-Jones, Namratha R Kandula, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 26, 2020
Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double-blinded, randomized-controlled trialSudhir Raj Thout, Jie Yu, Maoyi Tian, et al.
Journal of the American Heart Association|October 4, 2014
Association of 10-year and lifetime predicted cardiovascular disease risk with subclinical atherosclerosis in South Asians: findings from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) studyNamratha R Kandula, Alka M Kanaya, Kiang Liu, et al.
Circulation|November 6, 2016
Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of CardiologyDonald M Lloyd-Jones, Mark D Huffman, Kunal N Karmali, et al.
Journal of the American College of Cardiology|February 8, 2023
Medication Use for Cardiovascular Disease Prevention in 40 Low- and Middle-Income CountriesJingJing Z Zhu, Jennifer Manne-Goehler, Anubha Agarwal, et al.
International Journal of Epidemiology|August 16, 2015
Data Resource Profile: The Cardiovascular Disease Lifetime Risk Pooling ProjectJohn T Wilkins, Kunal N Karmali, Mark D Huffman, et al.
Journal of Clinical and Translational Science|December 10, 2024
Examining the impact of the QUARTET USA trial using the translational science benefits modelGuhan Iyer, Danielle Lazar, Abigail S Baldridge, et al.
BMC Health Services Research|September 6, 2023
Facilitators and barriers to optimal home blood pressure management in patients with hypertensive disorders of pregnancy in a tertiary care facility in Abuja, Nigeria: a qualitative research studyZainab Mahmoud, Adaego A Orji, Chukwuebuka F Okoye, et al.
Pageof 33

Showing results (161-170 of 325) with videos related to

Sort By:
Pageof 33
Journal of Clinical Hypertension (Greenwich, Conn.)|August 10, 2020
Monitoring and implementation of salt reduction initiatives in Africa: A systematic reviewDejen Yemane Tekle, Joseph Alvin Santos, Kathy Trieu, et al.
Journal of the American College of Cardiology|November 10, 2016
Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of CardiologyDonald M Lloyd-Jones, Mark D Huffman, Kunal N Karmali, et al.
Journal of the American Heart Association|November 23, 2020
Adverse Trends in Premature Cardiometabolic Mortality in the United States, 1999 to 2018Nilay S Shah, Donald M Lloyd-Jones, Namratha R Kandula, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 26, 2020
Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double-blinded, randomized-controlled trialSudhir Raj Thout, Jie Yu, Maoyi Tian, et al.
Journal of the American Heart Association|October 4, 2014
Association of 10-year and lifetime predicted cardiovascular disease risk with subclinical atherosclerosis in South Asians: findings from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) studyNamratha R Kandula, Alka M Kanaya, Kiang Liu, et al.
Circulation|November 6, 2016
Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of CardiologyDonald M Lloyd-Jones, Mark D Huffman, Kunal N Karmali, et al.
Journal of the American College of Cardiology|February 8, 2023
Medication Use for Cardiovascular Disease Prevention in 40 Low- and Middle-Income CountriesJingJing Z Zhu, Jennifer Manne-Goehler, Anubha Agarwal, et al.
International Journal of Epidemiology|August 16, 2015
Data Resource Profile: The Cardiovascular Disease Lifetime Risk Pooling ProjectJohn T Wilkins, Kunal N Karmali, Mark D Huffman, et al.
Journal of Clinical and Translational Science|December 10, 2024
Examining the impact of the QUARTET USA trial using the translational science benefits modelGuhan Iyer, Danielle Lazar, Abigail S Baldridge, et al.
BMC Health Services Research|September 6, 2023
Facilitators and barriers to optimal home blood pressure management in patients with hypertensive disorders of pregnancy in a tertiary care facility in Abuja, Nigeria: a qualitative research studyZainab Mahmoud, Adaego A Orji, Chukwuebuka F Okoye, et al.
Pageof 33